FDA Approves Expanded Liquid Biopsy Panel - Top_Thought_Leaders - MDSpire

FDA Approves Expanded Liquid Biopsy Panel

Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.

  • By

  • Kathryn Wighton

  • May 20, 2026

  • 2 min

Share

Top Thought Leaders in Neurology

Brief introduction explaining scope and methodology.

Original Source(s)

FDA Approves Expanded Liquid Biopsy Panel

  • by Kathryn Wighton

  • May 20, 2026

Related Content

Digital Pathology: the Great Translation Debate

Conference discussions highlighted collaboration, resilience, and the realities of AI adoption in pathology labs

DNA Quality Outweighs Bone Source

Background DNA burden was more strongly associated with sequencing profile completeness than bone source in unidentified human remains.

Could Digital Twins Forecast Forensic Risk?

Researchers outline a proposed three-level framework spanning patient monitoring, ward operations, and forensic system planning.